Grifols and Health Robotics Partner to Co-Market Products in the United States

Health Robotics has declared extending its existing agreement with Grifol for marketing in Europe to also cover the United States of America.

According to the agreement, Grifols which has a presence in Los-Angeles would co-market the products of Health Robotics, i.v.STATION ONCO, i.v.SOFT and i.v.STATION to Health System Pharmacies in the US.

The General Manager of Grifols’s USA Hospital Division was convinced about the portfolio of products from Health Robotics while attending technical training held at the robot factory of Health Robotics. He added that by merging the products with Grifols’ experience American customers would be presented with unique solutions that offer safety and financial benefits. He added that in the following week two additional partnerships with Health Robotics would be announced.

Grifols is a Spain based company that specialises in hospital-pharmaceutical sector. The company has established its presence in more than 90 countries. The Hospital Division of Grifols concentrates on the research and development and manufacturing of non-biological products that are used in clinics, hospitals and infusion centres. Health Robotics leads the global supply of life-critical intravenous medication robots. The company has installed these robots in more than 200 hospitals in six continents. Some of the leading products from Health Robotics are TPNstation, i.v.SOFT, i.v.ONCO and i.v.STATION.